home / stock / gud:cc / gud:cc quote
Last: | $5.57 |
---|---|
Change Percent: | -4.46% |
Open: | $5.83 |
Close: | $5.83 |
High: | $5.85 |
Low: | $5.55 |
Volume: | 163,115 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.57 | $5.83 | $5.83 | $5.85 | $5.55 | 163,115 | 08-02-2022 |
$5.32 | $5.31 | $5.32 | $5.35 | $5.31 | 262,397 | 05-06-2022 |
$5.32 | $5.32 | $5.32 | $5.4 | $5.3 | 266,151 | 05-05-2022 |
$5.35 | $5.39 | $5.35 | $5.4 | $5.33 | 673,778 | 05-04-2022 |
$5.4 | $5.31 | $5.4 | $5.4 | $5.31 | 294,385 | 05-03-2022 |
$5.31 | $5.31 | $5.31 | $5.35 | $5.31 | 311,660 | 05-02-2022 |
$5.33 | $5.33 | $5.33 | $5.39 | $5.31 | 189,343 | 04-29-2022 |
$5.33 | $5.33 | $5.33 | $5.39 | $5.32 | 240,987 | 04-28-2022 |
$5.32 | $5.32 | $5.32 | $5.345 | $5.315 | 316,204 | 04-27-2022 |
$5.32 | $5.31 | $5.32 | $5.34 | $5.31 | 324,670 | 04-26-2022 |
$5.33 | $5.35 | $5.33 | $5.36 | $5.3 | 434,613 | 04-25-2022 |
$5.37 | $5.35 | $5.37 | $5.4 | $5.34 | 797,363 | 04-22-2022 |
$5.35 | $5.35 | $5.35 | $5.37 | $5.35 | 254,562 | 04-21-2022 |
$5.38 | $5.34 | $5.38 | $5.38 | $5.33 | 206,345 | 04-20-2022 |
$5.36 | $5.33 | $5.36 | $5.37 | $5.33 | 163,144 | 04-19-2022 |
$5.33 | $5.3 | $5.33 | $5.37 | $5.3 | 169,608 | 04-18-2022 |
$5.35 | $5.32 | $5.35 | $5.36 | $5.31 | 148,639 | 04-15-2022 |
$5.35 | $5.32 | $5.35 | $5.36 | $5.31 | 148,639 | 04-14-2022 |
$5.33 | $5.33 | $5.33 | $5.37 | $5.31 | 178,611 | 04-13-2022 |
$5.32 | $5.31 | $5.32 | $5.34 | $5.3 | 207,351 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Knight Therapeutics Inc. Company Name:
GUD:CC Stock Symbol:
TSXC Market:
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive supply and distribution agreement with Ironshore Pharmaceuticals & Development, Inc., a wh...
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2024. All currency amounts are in ...
Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...